PDB Short entry for 2I0J HEADER TRANSCRIPTION 10-AUG-06 2I0J TITLE BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) TITLE 2 WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR ALPHA; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: STEROID BINDING DOMAIN; COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET19 KEYWDS NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG REVDAT 5 30-AUG-23 2I0J 1 REMARK REVDAT 4 20-OCT-21 2I0J 1 REMARK SEQADV REVDAT 3 18-OCT-17 2I0J 1 REMARK REVDAT 2 24-FEB-09 2I0J 1 VERSN REVDAT 1 24-OCT-06 2I0J 0 JRNL AUTH B.H.NORMAN,J.A.DODGE,T.I.RICHARDSON,P.S.BORROMEO,C.W.LUGAR, JRNL AUTH 2 S.A.JONES,K.CHEN,Y.WANG,G.L.DURST,R.J.BARR, JRNL AUTH 3 C.MONTROSE-RAFIZADEH,H.E.OSBORNE,R.M.AMOS,S.GUO,A.BOODHOO, JRNL AUTH 4 V.KRISHNAN JRNL TITL BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS JRNL TITL 2 WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC JRNL TITL 3 HYPERPLASIA. JRNL REF J.MED.CHEM. V. 49 6155 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 17034120 JRNL DOI 10.1021/JM060491J REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1319503.500 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.6 REMARK 3 NUMBER OF REFLECTIONS : 20086 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1039 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 20086 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2222 REMARK 3 BIN R VALUE (WORKING SET) : 0.3770 REMARK 3 BIN FREE R VALUE : 0.4000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 115 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7134 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 13.74000 REMARK 3 B22 (A**2) : -21.03000 REMARK 3 B33 (A**2) : 7.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 21.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM SIGMAA (A) : 0.62 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.70 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.290 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.290 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.650 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.740 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 45.53 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : LIG.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIG.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2I0J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000038984. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20086 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 57.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.35500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1A52 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, 0.2M MAGNESIUM CHLORIDE, REMARK 280 20% PEG 4000, 10% ETHYLENE GLYCOL, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 289.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 86.57200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS TWO BIOLOGICAL UNITS. ONE REMARK 300 BIOLOGICAL UNIT CONSISTS OF CHAINS A AND B, THE OTHER C AND D. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 LYS A 529 REMARK 465 SER A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 VAL A 533 REMARK 465 VAL A 534 REMARK 465 PRO A 535 REMARK 465 LEU A 536 REMARK 465 TYR A 537 REMARK 465 ASP A 538 REMARK 465 LEU A 539 REMARK 465 LEU A 540 REMARK 465 LEU A 541 REMARK 465 GLU A 542 REMARK 465 MET A 543 REMARK 465 LEU A 544 REMARK 465 ASP A 545 REMARK 465 ALA A 546 REMARK 465 HIS A 547 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 337 REMARK 465 SER B 338 REMARK 465 GLU B 339 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 ASN C 304 REMARK 465 SER C 305 REMARK 465 LYS C 529 REMARK 465 SER C 530 REMARK 465 LYS C 531 REMARK 465 ASN C 532 REMARK 465 VAL C 533 REMARK 465 VAL C 534 REMARK 465 PRO C 535 REMARK 465 LEU C 536 REMARK 465 TYR C 537 REMARK 465 ASP C 538 REMARK 465 LEU C 539 REMARK 465 LEU C 540 REMARK 465 LEU C 541 REMARK 465 GLU C 542 REMARK 465 MET C 543 REMARK 465 LEU C 544 REMARK 465 ASP C 545 REMARK 465 ALA C 546 REMARK 465 HIS C 547 REMARK 465 ASN D 304 REMARK 465 SER D 305 REMARK 465 PRO D 333 REMARK 465 THR D 334 REMARK 465 ARG D 335 REMARK 465 PRO D 336 REMARK 465 PHE D 337 REMARK 465 SER D 338 REMARK 465 GLU D 339 REMARK 465 ALA D 340 REMARK 465 LEU D 462 REMARK 465 SER D 463 REMARK 465 LYS D 529 REMARK 465 SER D 530 REMARK 465 LYS D 531 REMARK 465 ASN D 532 REMARK 465 VAL D 533 REMARK 465 VAL D 534 REMARK 465 PRO D 535 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 337 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG C 335 CG CD NE CZ NH1 NH2 REMARK 470 PHE C 337 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU C 339 N SER C 341 2.05 REMARK 500 O GLU A 339 N SER A 341 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 336 C - N - CA ANGL. DEV. = -9.3 DEGREES REMARK 500 PRO C 336 C - N - CA ANGL. DEV. = -9.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 331 137.14 176.01 REMARK 500 THR A 334 149.43 -37.20 REMARK 500 ARG A 335 -95.96 90.10 REMARK 500 PRO A 336 -146.99 -144.91 REMARK 500 SER A 338 53.96 -0.83 REMARK 500 GLU A 339 -9.38 53.22 REMARK 500 ALA A 340 62.64 -8.83 REMARK 500 SER A 341 108.77 23.68 REMARK 500 VAL A 392 -30.46 -37.45 REMARK 500 GLU A 397 30.38 -95.20 REMARK 500 HIS A 398 56.56 -142.97 REMARK 500 LEU A 408 74.55 -154.08 REMARK 500 SER A 468 -73.59 -47.99 REMARK 500 TYR B 331 168.44 170.11 REMARK 500 SER B 341 125.51 -22.01 REMARK 500 VAL B 392 -31.72 -38.91 REMARK 500 GLU B 397 30.43 -98.30 REMARK 500 HIS B 398 56.02 -143.42 REMARK 500 LEU B 408 75.88 -156.10 REMARK 500 THR B 465 -160.14 -64.03 REMARK 500 LEU B 536 -58.07 0.17 REMARK 500 TYR C 331 136.87 175.96 REMARK 500 THR C 334 149.22 -37.30 REMARK 500 ARG C 335 -95.77 90.19 REMARK 500 PRO C 336 -147.97 -145.38 REMARK 500 SER C 338 54.07 0.25 REMARK 500 GLU C 339 -7.97 52.40 REMARK 500 ALA C 340 60.23 -7.89 REMARK 500 SER C 341 108.17 24.81 REMARK 500 VAL C 392 -30.83 -37.69 REMARK 500 GLU C 397 30.97 -94.28 REMARK 500 HIS C 398 56.06 -143.69 REMARK 500 LEU C 408 74.71 -155.97 REMARK 500 LEU C 462 -74.59 -12.75 REMARK 500 SER C 468 -73.27 -48.06 REMARK 500 TYR D 331 168.04 169.98 REMARK 500 VAL D 392 -31.95 -39.31 REMARK 500 GLU D 397 30.43 -96.80 REMARK 500 HIS D 398 56.27 -143.81 REMARK 500 LEU D 408 76.42 -156.73 REMARK 500 THR D 465 -159.34 -63.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I0G A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I0G B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I0G C 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I0G D 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I0G RELATED DB: PDB DBREF 2I0J A 304 547 UNP P03372 ESR1_HUMAN 304 547 DBREF 2I0J B 304 547 UNP P03372 ESR1_HUMAN 304 547 DBREF 2I0J C 304 547 UNP P03372 ESR1_HUMAN 304 547 DBREF 2I0J D 304 547 UNP P03372 ESR1_HUMAN 304 547 SEQADV 2I0J SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2I0J SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2I0J SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 2I0J SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2I0J SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2I0J SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 2I0J SER C 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2I0J SER C 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2I0J SER C 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 2I0J SER D 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2I0J SER D 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2I0J SER D 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQRES 1 A 244 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 A 244 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 A 244 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 A 244 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 A 244 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 A 244 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 A 244 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 A 244 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 A 244 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 A 244 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 A 244 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 A 244 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 A 244 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 A 244 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 A 244 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 A 244 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 A 244 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 A 244 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 A 244 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 1 B 244 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 B 244 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 B 244 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 B 244 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 B 244 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 B 244 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 B 244 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 B 244 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 B 244 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 B 244 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 B 244 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 B 244 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 B 244 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 B 244 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 B 244 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 B 244 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 B 244 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 B 244 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 B 244 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 1 C 244 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 C 244 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 C 244 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 C 244 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 C 244 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 C 244 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 C 244 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 C 244 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 C 244 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 C 244 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 C 244 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 C 244 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 C 244 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 C 244 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 C 244 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 C 244 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 C 244 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 C 244 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 C 244 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 1 D 244 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 D 244 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 D 244 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 D 244 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 D 244 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 D 244 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 D 244 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 D 244 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 D 244 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 D 244 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 D 244 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 D 244 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 D 244 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 D 244 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 D 244 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 D 244 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 D 244 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 D 244 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 D 244 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS HET I0G A 1 21 HET I0G B 1 21 HET I0G C 1 21 HET I0G D 1 21 HETNAM I0G (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B- HETNAM 2 I0G HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL FORMUL 5 I0G 4(C18 H18 O3) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 341 LYS A 362 1 22 HELIX 4 4 THR A 371 SER A 395 1 25 HELIX 5 5 ASN A 413 VAL A 418 5 6 HELIX 6 6 GLY A 420 ASN A 439 1 20 HELIX 7 7 GLN A 441 GLY A 457 1 17 HELIX 8 8 VAL A 458 PHE A 461 5 4 HELIX 9 9 THR A 465 ALA A 493 1 29 HELIX 10 10 THR A 496 TYR A 526 1 31 HELIX 11 11 LEU B 306 LEU B 310 5 5 HELIX 12 12 THR B 311 GLU B 323 1 13 HELIX 13 13 SER B 341 VAL B 364 1 24 HELIX 14 14 THR B 371 SER B 395 1 25 HELIX 15 15 ASN B 413 VAL B 418 5 6 HELIX 16 16 GLY B 420 ASN B 439 1 20 HELIX 17 17 GLN B 441 GLY B 457 1 17 HELIX 18 18 VAL B 458 THR B 460 5 3 HELIX 19 19 THR B 465 ALA B 493 1 29 HELIX 20 20 THR B 496 SER B 527 1 32 HELIX 21 21 PRO B 535 ASP B 545 1 11 HELIX 22 22 LEU C 306 LEU C 310 5 5 HELIX 23 23 THR C 311 GLU C 323 1 13 HELIX 24 24 SER C 341 LYS C 362 1 22 HELIX 25 25 THR C 371 SER C 395 1 25 HELIX 26 26 ASN C 413 VAL C 418 5 6 HELIX 27 27 GLY C 420 ASN C 439 1 20 HELIX 28 28 GLN C 441 GLY C 457 1 17 HELIX 29 29 VAL C 458 PHE C 461 5 4 HELIX 30 30 THR C 465 ALA C 493 1 29 HELIX 31 31 THR C 496 MET C 528 1 33 HELIX 32 32 LEU D 306 LEU D 310 5 5 HELIX 33 33 THR D 311 GLU D 323 1 13 HELIX 34 34 SER D 341 VAL D 364 1 24 HELIX 35 35 THR D 371 SER D 395 1 25 HELIX 36 36 ASN D 413 VAL D 418 5 6 HELIX 37 37 GLY D 420 ASN D 439 1 20 HELIX 38 38 GLN D 441 GLY D 457 1 17 HELIX 39 39 VAL D 458 PHE D 461 5 4 HELIX 40 40 THR D 465 ALA D 493 1 29 HELIX 41 41 THR D 496 SER D 527 1 32 HELIX 42 42 LEU D 536 ASP D 545 1 10 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 SHEET 1 C 2 LYS C 401 ALA C 405 0 SHEET 2 C 2 LEU C 408 ASP C 411 -1 O LEU C 410 N LEU C 402 SHEET 1 D 2 LYS D 401 ALA D 405 0 SHEET 2 D 2 LEU D 408 ASP D 411 -1 O LEU D 410 N LEU D 402 SITE 1 AC1 8 GLU A 353 LEU A 384 LEU A 387 ARG A 394 SITE 2 AC1 8 PHE A 404 MET A 421 ILE A 424 HIS A 524 SITE 1 AC2 9 LEU B 349 GLU B 353 LEU B 384 LEU B 387 SITE 2 AC2 9 ARG B 394 MET B 421 ILE B 424 HIS B 524 SITE 3 AC2 9 LEU B 525 SITE 1 AC3 7 GLU C 353 LEU C 384 ARG C 394 PHE C 404 SITE 2 AC3 7 MET C 421 ILE C 424 HIS C 524 SITE 1 AC4 9 LEU D 349 GLU D 353 LEU D 384 LEU D 387 SITE 2 AC4 9 ARG D 394 MET D 421 ILE D 424 HIS D 524 SITE 3 AC4 9 LEU D 525 CRYST1 58.503 173.144 58.522 90.00 119.48 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017093 0.000000 0.009662 0.00000 SCALE2 0.000000 0.005776 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019629 0.00000